(Q36267453)

English

The significance of high follicular-phase luteinizing hormone levels in the treatment of women with polycystic ovarian syndrome by in vitro fertilization

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

1 reference

Europe PubMed Central

The significance of high follicular-phase luteinizing hormone levels in the treatment of women with polycystic ovarian syndrome by in vitro fertilization (English)

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

author name string

Tarlatzis BC

1

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Grimbizis G

2

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

publication date

1 January 1997

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Journal of Assisted Reproduction and Genetics

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

14

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

1

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

1-4

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Polycystic ovarian disease (PCOD)--pregnancy rate and outcome in in vitro fertilization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3454715

30 September 2017

Assisted reproduction techniques in polycystic ovarian syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3454715

30 September 2017

Hypersecretion of luteinising hormone: a significant cause of infertility and miscarriage.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3454715

30 September 2017

Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3454715

30 September 2017

The use of a short regimen of buserelin, a gonadotrophin-releasing hormone agonist, and human menopausal gonadotrophin in assisted conception cycles

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3454715

30 September 2017

Recurrent spontaneous abortion and polycystic ovarian disease: comparison of two regimens to induce ovulation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3454715

30 September 2017

Low-dose gonadotrophin therapy for induction of ovulation in 100 women with polycystic ovary syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3454715

30 September 2017

The prognostic value of basal luteinizing hormone:follicle-stimulating hormone ratio in the treatment of patients with polycystic ovarian syndrome by assisted reproduction techniques

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3454715

29 June 2018

Premature luteinization is not eliminated by pituitary desensitization with leuprolide acetate in women undergoing gonadotrophin stimulation who demonstrated premature luteinization in a prior gonadotrophin-only cycle

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3454715

29 June 2018

In vitro fertilization and embryo transfer for the treatment of infertility associated with polycystic ovary syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3454715

29 June 2018

Successful induction of ovulation and conception with combined gonadotropin-releasing hormone agonist plus highly purified follicle-stimulating hormone in patients with polycystic ovarian disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3454715

29 June 2018

The treatment of patients with polycystic ovarian syndrome by in-vitro fertilization and embryo transfer: a comparison of results with those of patients with tubal infertility.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3454715

29 June 2018

The effect of gonadotropin-releasing hormone agonist on the ovarian response and in vitro fertilization results in polycystic ovarian syndrome: a prospective study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3454715

29 June 2018

A comparative study of three ovulation induction protocols in polycystic ovarian disease patients in an in vitro fertilization/embryo transfer program

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3454715

22 September 2018

Hypersecretion of luteinizing hormone and ovarian steroids in women with recurrent early miscarriage

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3454715

22 September 2018

Transvaginal ultrasound imaging, histopathology and endocrinopathy in patients with polycystic ovarian syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/9013299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced in-vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase

1 reference

https://pubmed.ncbi.nlm.nih.gov/9013299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of high tonic levels of luteinising hormone on outcome of in-vitro fertilisation

1 reference

https://pubmed.ncbi.nlm.nih.gov/9013299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined GnRH-agonist/gonadotrophin stimulation for in-vitro fertilization

1 reference

https://pubmed.ncbi.nlm.nih.gov/9013299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gonadotropin-releasing hormone agonist reduces the miscarriage rate for pregnancies achieved in women with polycystic ovarian syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/9013299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is endometrial development in the peri-implantation period influenced by high concentrations of luteinizing hormone in the follicular phase?

1 reference

https://pubmed.ncbi.nlm.nih.gov/9013299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF02765740

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

release_e4szrxvjczdpvlimx5qegokvk4

1 reference

https://api.fatcat.wiki/v0/release/e4szrxvjczdpvlimx5qegokvk4

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36267453&oldid=2198501535"